Crigler-Najjar syndrome type 2 (Q91609): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed label, description and/or aliases in pt-br, en
‎Changed an Item
 
(5 intermediate revisions by the same user not shown)
Property / Canonical URI
 
Property / Canonical URI: https://id.who.int/icd/entity/846453488 / rank
 
Normal rank
Property / CURIE
 
CID11:ID_846453488
Property / CURIE: CID11:ID_846453488 / rank
 
Normal rank
Property / Canary Token
 
dki-india-ID_846453488
Property / Canary Token: dki-india-ID_846453488 / rank
 
Normal rank
Property / Verification Status
 
Concluído
Property / Verification Status: Concluído / rank
 
Normal rank
Property / Knowledge Architect
 
Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank
 
Normal rank
Property / Collection date
 
13 August 2026
Timestamp+2026-08-13T00:00:00Z
Timezone+00:00
CalendarGregorian
Precision1 day
Before0
After0
Property / Collection date: 13 August 2026 / rank
 
Normal rank

Latest revision as of 18:38, 15 August 2026

Type 2 Crigler-Najjar syndrome is a hereditary disorder of bilirubin metabolism characterised by unconjugated hyperbilirubinemia due to reduced and inducible activity of hepatic bilirubin glucuronosyltransferase (GT). CNS2 is a milder form of CNS than CNS1 (see these terms). First clinical manifestations usually appear soon after birth. CNS2 patients are less severely jaundiced than CNS1 patients, have pigmented bile that contains bilirubin glucuronides, and generally do not present neurologic or intellectual impairment. Bilirubin encephalopathy may develop in later life when patients experience a superimposed infection or stress.
Language Label Description Also known as
default for all languages
ID_846453488
    English
    Crigler-Najjar syndrome type 2
    Type 2 Crigler-Najjar syndrome is a hereditary disorder of bilirubin metabolism characterised by unconjugated hyperbilirubinemia due to reduced and inducible activity of hepatic bilirubin glucuronosyltransferase (GT). CNS2 is a milder form of CNS than CNS1 (see these terms). First clinical manifestations usually appear soon after birth. CNS2 patients are less severely jaundiced than CNS1 patients, have pigmented bile that contains bilirubin glucuronides, and generally do not present neurologic or intellectual impairment. Bilirubin encephalopathy may develop in later life when patients experience a superimposed infection or stress.

      Statements

      CID11:ID_846453488
      0 references
      dki-india-ID_846453488
      0 references
      Concluído
      0 references
      13 August 2026
      0 references